Adam Mossoff is Professor of Law at Antonin Scalia Law School, George Mason University. He has published extensively on why patents, copyrights, and other intellectual property rights have been—and should be—legally secured to innovators and creators as property rights. His scholarship has been relied on by the United States Supreme Court, by lower federal courts, and by U.S. federal agencies. He has been invited to testify numerous times before the U.S. Senate and the House of Representatives on intellectual property legislation. His writings on intellectual property policy have also appeared in the Wall Street Journal, New York Times, Forbes, Investors Business Daily, and in other media outlets. His journal articles can be downloaded here.
Professor Mossoff is a longstanding member of the Executive Committee of the Intellectual Property Practice Group of the Federalist Society, on which he served as Chairperson from 2016-2018, and he is Chair of the Intellectual Property Working Group of the Regulatory Transparency Project of the Federalist Society. He is a Senior Fellow and Chair of the Forum for Intellectual Property at the Hudson Institute, a Visiting Intellectual Property Fellow at the Heritage Foundation, and a member of the Board of Directors of the Center for Intellectual Property Understanding. He is a member of the Intellectual Property Rights Policy Committee of ANSI and he has served as Chair and Vice-Chair of the Intellectual Property Committee of the IEEE-USA, on which he remains a member in good standing.
Deep Dive Episode 156 – Incentivizing Drug Development: Patents or Prizes?
Regulatory Transparency Project's Fourth Branch Pdcast
TeleforumDeep Dive Episode 143 – Pandemics & Patents: Do Patents Help or Hinder Medical Innovation?
Regulatory Transparency Project's Fourth Branch Podcast
Zoom Webinar -- Akron150 University Ave
Akron, OH 44325
Deep Dive Episode 118 – Can Patents and Bayh-Dole Fuel Innovation in the Time of COVID-19?
Regulatory Transparency Project Teleforum
TeleforumDeep Dive Episode 156 – Incentivizing Drug Development: Patents or Prizes?
Regulatory Transparency Project's Fourth Branch Pdcast
Medical innovation has made modern life miraculous by historical standards, as demonstrated by the unprecedented...
Deep Dive Episode 155 – International Reference Pricing and Negotiation: Yes or No?
Regulatory Transparency Project's Fourth Branch Podcast
Drug prices are a pressing policy issue. On November 20, 2020, President Donald Trump announced two new...
International Reference Pricing and Negotiation: Yes or No?
Drug prices are a pressing policy issue. On November 20, 2020, President Donald Trump announced two new...
Deep Dive Episode 143 – Pandemics & Patents: Do Patents Help or Hinder Medical Innovation?
Regulatory Transparency Project's Fourth Branch Podcast
On October 28, 2020 the Federalist Society's Akron Student Chapter hosted George Horvath and Adam...
Deep Dive Episode 118 – Can Patents and Bayh-Dole Fuel Innovation in the Time of COVID-19?
Regulatory Transparency Project Teleforum
Activists and politicians have responded to the worldwide COVID-19 pandemic by calling for the elimination...